T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation

Immunity

Volumn 48, Issue 4, 2018, Pages 745-759.e6

  Tu, Eric ^a   Chia, Cheryl P Z ^a   Chen, Weiwei ^b   Zhang, Dunfang ^a   Park, Sang A ^a   Jin, Wenwen ^a   Wang, Dandan ^b   Alegre, Maria Luisa ^c   Zhang, Ying E ^d   Sun, Lingyun ^b   Chen, WanJun ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c UNIVERSITY OF CHICAGO   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

autoimmunity; CARD11; IL 6; NF kB; receptor I downregulation; signaling; T cell activation; T cell quiescence; TCR signaling; TGF

Indexed keywords

CASPASE RECRUITMENT DOMAIN CONTAINING PROTEIN 11; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; CARD11 PROTEIN, HUMAN; GUANYLATE CYCLASE; IL6 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TGF BETA SIGNALING; ANIMAL; AUTOIMMUNITY; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL PROLIFERATION; COLITIS; DISEASE MODEL; DOWN REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; CARD SIGNALING ADAPTOR PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; COLITIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GUANYLATE CYCLASE; HEK293 CELLS; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA TYPE I; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85045006134     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.03.025     Document Type: Article

References (46)

1. Boothby, M.R., Mora, A.L., Scherer, D.C., Brockman, J.A., Ballard, D.W., Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J. Exp. Med. 185 (1997), 1897–1907.
2. Chang, M., Jin, W., Chang, J.H., Xiao, Y., Brittain, G.C., Yu, J., Zhou, X., Wang, Y.H., Cheng, X., Li, P., et al. The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nat. Immunol. 12 (2011), 1002–1009.
3. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., Wahl, S.M., Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003), 1875–1886.
4. Chikuma, S., Suita, N., Okazaki, I.M., Shibayama, S., Honjo, T., TRIM28 prevents autoinflammatory T cell development in vivo. Nat. Immunol. 13 (2012), 596–603.
5. Cortez, V.S., Ulland, T.K., Cervantes-Barragan, L., Bando, J.K., Robinette, M.L., Wang, Q., White, A.J., Gilfillan, S., Cella, M., Colonna, M., SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling. Nat. Immunol. 18 (2017), 995–1003.
6. Daniels, M.A., Teixeiro, E., Gill, J., Hausmann, B., Roubaty, D., Holmberg, K., Werlen, G., Holländer, G.A., Gascoigne, N.R., Palmer, E., Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444 (2006), 724–729.
7. Derynck, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003), 577–584.
8. Egawa, T., Albrecht, B., Favier, B., Sunshine, M.J., Mirchandani, K., O'Brien, W., Thome, M., Littman, D.R., Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr. Biol. 13 (2003), 1252–1258.
9. Egen, J.G., Allison, J.P., Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16 (2002), 23–35.
10. Fahlén, L., Read, S., Gorelik, L., Hurst, S.D., Coffman, R.L., Flavell, R.A., Powrie, F., T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201 (2005), 737–746.
11. Feng, X., Wang, H., Takata, H., Day, T.J., Willen, J., Hu, H., Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat. Immunol. 12 (2011), 544–550.
12. Fontenot, J.D., Gavin, M.A., Rudensky, A.Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003), 330–336.
13. Giroux, M., Delisle, J.S., O'Brien, A., Hébert, M.J., Perreault, C., T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling. J. Immunol. 185 (2010), 1568–1576.
14. Gorelik, L., Flavell, R.A., Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat. Med. 7 (2001), 1118–1122.
15. Gottschalk, R.A., Corse, E., Allison, J.P., TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207 (2010), 1701–1711.
16. Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003), 1057–1061.
17. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
18. Kasagi, S., Zhang, P., Che, L., Abbatiello, B., Maruyama, T., Nakatsukasa, H., Zanvit, P., Jin, W., Konkel, J.E., Chen, W., In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci. Transl. Med., 6, 2014, 241ra78.
19. Konkel, J.E., Zhang, D., Zanvit, P., Chia, C., Zangarle-Murray, T., Jin, W., Wang, S., Chen, W., Transforming growth factor-β signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity 46 (2017), 660–674.
20. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T.R., Bäckström, B.T., Sobel, R.A., Wucherpfennig, K.W., Strom, T.B., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007), 423–431.
21. Krogsgaard, M., Prado, N., Adams, E.J., He, X.L., Chow, D.C., Wilson, D.B., Garcia, K.C., Davis, M.M., Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 12 (2003), 1367–1378.
22. Li, M.O., Sanjabi, S., Flavell, R.A., Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006), 455–471.
23. Liu, Y., Zhang, P., Li, J., Kulkarni, A.B., Perruche, S., Chen, W., A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol. 9 (2008), 632–640.
24. Marie, J.C., Liggitt, D., Rudensky, A.Y., Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25 (2006), 441–454.
25. Molinero, L.L., Miller, M.L., Evaristo, C., Alegre, M.L., High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J. Immunol. 186 (2011), 4609–4617.
26. Nakamura, K., Kitani, A., Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 (2001), 629–644.
27. Nakao, A., Afrakhte, M., Morén, A., Nakayama, T., Christian, J.L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.E., Heldin, C.H., ten Dijke, P., Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (1997), 631–635.
28. Nakatsukasa, H., Zhang, D., Maruyama, T., Chen, H., Cui, K., Ishikawa, M., Deng, L., Zanvit, P., Tu, E., Jin, W., et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat. Immunol. 16 (2015), 1077–1084.
29. Natarajan, K., Singh, S., Burke, T.R. Jr., Grunberger, D., Aggarwal, B.B., Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 93 (1996), 9090–9095.
30. Ruegemer, J.J., Ho, S.N., Augustine, J.A., Schlager, J.W., Bell, M.P., McKean, D.J., Abraham, R.T., Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. J. Immunol. 144 (1990), 1767–1776.
31. Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance. Cell 133 (2008), 775–787.
32. Shi, Y., Massagué, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003), 685–700.
33. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 (1992), 693–699.
34. Smith-Garvin, J.E., Koretzky, G.A., Jordan, M.S., T cell activation. Annu. Rev. Immunol. 27 (2009), 591–619.
35. Takada, K., Jameson, S.C., Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9 (2009), 823–832.
36. Thomas, D.A., Massagué, J., TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8 (2005), 369–380.
37. Tu, E., Bourges, D., Gleeson, P.A., Ang, D.K., van Driel, I.R., Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells. Eur. J. Immunol. 43 (2013), 1286–1296.
38. Tu, E., Chia, P.Z., Chen, W., TGFβ in T cell biology and tumor immunity: Angel or devil?. Cytokine Growth Factor Rev. 25 (2014), 423–435.
39. Tzachanis, D., Freeman, G.J., Hirano, N., van Puijenbroek, A.A., Delfs, M.W., Berezovskaya, A., Nadler, L.M., Boussiotis, V.A., Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2 (2001), 1174–1182.
40. Wang, L., Walia, B., Evans, J., Gewirtz, A.T., Merlin, D., Sitaraman, S.V., IL-6 induces NF-kappa B activation in the intestinal epithelia. J. Immunol. 171 (2003), 3194–3201.
41. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., Mak, T.W., Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 (1995), 985–988.
42. Yang, X., Letterio, J.J., Lechleider, R.J., Chen, L., Hayman, R., Gu, H., Roberts, A.B., Deng, C., Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18 (1999), 1280–1291.
43. Yang, K., Neale, G., Green, D.R., He, W., Chi, H., The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12 (2011), 888–897.
44. Yu, L., Hébert, M.C., Zhang, Y.E., TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 (2002), 3749–3759.
45. Zanvit, P., Konkel, J.E., Jiao, X., Kasagi, S., Zhang, D., Wu, R., Chia, C., Ajami, N.J., Smith, D.P., Petrosino, J.F., et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat. Commun., 6, 2015, 8424.
46. Zhou, L., Lopes, J.E., Chong, M.M., Ivanov, I.I., Min, R., Victora, G.D., Shen, Y., Du, J., Rubtsov, Y.P., Rudensky, A.Y., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453 (2008), 236–240.